Praziquantel-encapsulated niosomes against Schistosoma mansoni with reduced sensitivity to praziquantel

INTRODUCTION: Praziquantel (PZQ) is the only commercially available drug for schistosomiasis. The current shortage of alternative effective drugs and the lack of successful preventive measures enhance its value. The increase in the prevalence of PZQ resistance under sustained drug pressure is, there...

Descripción completa

Detalles Bibliográficos
Autores principales: Amer, Eglal I., Abou-El-Naga, Iman F., Boulos, Laila M., Ramadan, Heba S., Younis, Salwa S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Instituto Nacional de Salud 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9059922/
https://www.ncbi.nlm.nih.gov/pubmed/35471171
http://dx.doi.org/10.7705/biomedica.5913

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9059922/
https://www.ncbi.nlm.nih.gov/pubmed/35471171
http://dx.doi.org/10.7705/biomedica.5913

Ejemplares similares